Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time.

Heleen M A HendriksenTanja J de RijkeAgnetha FruijtierElsmarieke van de GiessenArgonde C van HartenMardou S S A van Leeuwenstijn-KoopmanJetske van der SchaarCalvin TrieuDenise VisserEllen M A SmetsLeonie N C VisserWiesje M van der Flier

Published in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2024)

Participants with subjective cognitive decline (SCD) positively valued amyloid positron emission tomography (PET) disclosure. Participants with SCD experienced low levels of decision regret. We did not observe an increase in negative emotions. After 6 months, amyloid-positive individuals wanted more information.

Keyphrases

cognitive decline
positron emission tomography
computed tomography
mild cognitive impairment
pet ct
pet imaging
sleep quality
mental health
healthcare
health information
depressive symptoms
decision making
physical activity